Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 358
Last updated 2017-06-01
Summary
Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
Conditions
- Myocardial Infarction
- Death, Sudden, Cardiac
Interventions
- DRUG
-
Omega-3 Fatty Acids (Fish Oil Supplements)
4 grams of omega-3 fatty acids taken orally once per day for 6 months
- DRUG
-
Placebo tablets taken orally once per day for 6 months
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - collaborator INDUSTRY
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Raymond Y. Kwong, MD, MPH · Brigham and Women's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2013-10-31
- Completion
- 2014-07-31
Countries
- United States
Study Locations
More Related Trials
-
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
NCT00251134 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872 ·Status: COMPLETED
-
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
NCT02271230 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT05822141 ·Status: RECRUITING ·Phase: NA
-
Effects of Fish Oil on Post Ablation Arrhythmias
NCT00791089 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes
NCT04796207 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction
NCT01841944 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
NCT00944229 ·Status: TERMINATED ·Phase: PHASE3
-
Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
NCT01235130 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial
NCT00290056 ·Status: UNKNOWN ·Phase: PHASE4
-
Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study
NCT01400490 ·Status: UNKNOWN ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
NCT00116857 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults
NCT02514070 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
NCT04496154 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
NCT00552084 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Biomarkers of Cardiovascular Risk
NCT00527436 ·Status: TERMINATED ·Phase: NA
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA